For the quarter ending 2026-03-31, EPR had -$24,092K decrease in cash & cash equivalents over the period. $76,932K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 62,610 | 66,904 | 66,586 | 141,446 |
| Impairment, long-lived asset, held-for-use | - | 0 | 0 | - |
| Impairment charges on joint ventures | - | 0 | 0 | - |
| Gain on real estate transactions | 1,027 | 5,297 | 8,073 | 26,163 |
| Deferred income tax expense (benefit) | 114 | -170 | -53 | -623 |
| Financing receivable, credit loss, expense (reversal) | -5,597 | -985 | 9,117 | 345 |
| Costs associated with loan refinancing or payoff | - | 0 | 0 | - |
| Equity in loss from joint ventures | -2,632 | -2,396 | 2,934 | -4,328 |
| Proceeds from equity method investment, distribution | 0 | 0 | 0 | 11 |
| Asset impairment charges | - | - | - | 0 |
| Depreciation and amortization | 44,957 | 43,582 | 42,409 | 83,169 |
| Amortization of deferred financing costs | 2,672 | 2,380 | 2,120 | 4,308 |
| Amortization of above/below market leases and tenant allowances, net | -81 | -81 | -81 | -162 |
| Share-based payment arrangement, noncash expense | 4,099 | 3,643 | 3,907 | 7,779 |
| Share based compensation included in severance expense | 1,041 | 1,328 | 847 | 0 |
| Increase (decrease) in operating lease assets and liabilities, net | -520 | -532 | -496 | -552 |
| Mortgage notes accrued interest receivable | 956 | -1,449 | 1,824 | 421 |
| Accounts receivable | 3,431 | 4,307 | -2,209 | 12,481 |
| Other assets | 3,374 | -1,238 | -1,318 | 4,877 |
| Accounts payable and accrued liabilities | 17,089 | -15,141 | 15,929 | -6,401 |
| Increase (decrease) in deferred revenue | -6,861 | 1,373 | 5,502 | -3,016 |
| Net cash provided by operating activities | 113,367 | 97,780 | 136,483 | 186,690 |
| Payments to acquire productive assets | 36,435 | 127,835 | 4,373 | 19,541 |
| Proceeds from sale of productive assets | 0 | 15,579 | 19,261 | 106,436 |
| Investment in unconsolidated joint ventures | - | 665 | 1,432 | 0 |
| Payments for (proceeds from) derivative instrument, investing activities | - | 0 | - | - |
| Investment in mortgage notes receivable | 1,375 | 1,742 | 38,297 | 9,776 |
| Proceeds from sale and collection of mortgage notes receivable | 124 | 18,672 | 175 | 9,458 |
| Investment in promissory notes receivable | - | 0 | - | - |
| Proceeds from promissory note receivable paydown | 91 | 185 | 980 | 279 |
| Additions to properties under development | 13,270 | 19,369 | 12,643 | 57,033 |
| Net cash (used) provided by investing activities | -50,865 | -115,175 | -36,329 | 29,823 |
| Proceeds from long-term debt facilities | 0 | 588,000 | 70,000 | 414,000 |
| Repayments of long-term debt | 0 | 417,000 | 96,000 | 484,000 |
| Deferred financing fees paid | 58 | 11,653 | 0 | 446 |
| Proceeds from (payment for) other financing activity | - | 0 | 0 | - |
| Net proceeds from issuance of common shares | 226 | 240 | 245 | 464 |
| Payment, tax withholding, share-based payment arrangement | - | 0 | 1 | - |
| Purchase of common shares for treasury | 13,144 | 22 | 0 | 9,833 |
| Dividends paid to shareholders | 73,495 | 73,327 | 73,302 | 144,091 |
| Net cash used by financing activities | -86,471 | 86,238 | -99,058 | -223,906 |
| Effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents | -123 | 113 | -124 | 414 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | -24,092 | 68,956 | 972 | -6,979 |
| Cash and cash equivalents at beginning of period | - | - | 35,699 | - |
| Cash and cash equivalents at end of period | - | - | 29,692 | - |
EPR PROPERTIES (EPR)
EPR PROPERTIES (EPR)